Literature DB >> 1709833

How to select Plasmodium falciparum pre-erythrocytic antigens in an expression library without defined probe.

C Marchand1, P Druilhe.   

Abstract

The restricted access to Plasmodium falciparum liver stages has greatly limited the analysis of the antigenic content of that stage. Due to the lack of material to perform immunochemical studies, of access to mRNA, and of monoclonal probes, we decided to screen a genomic library with stage-restricted human antibodies. This strategy led to the identification of a large number of DNA fragments encoding both sporozoite specific as well as liver-stage specific epitopes. Following the initial characterization of one liver-stage antigen, further screening was performed by using additional selective human antibodies. These were defined as having a high degree of reactivity with native antigens on either of the two stages while being negative with the already known molecules of the two stages. From this second screening and the study of cross-reactions, several subsets of DNA clones expressing antigens present on the surface of sporozoites, or in liver stages, or in both, could be identified. In exposed individuals a high prevalence of antibodies to several of these antigens was found.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1709833      PMCID: PMC2393044     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

1.  Evidence for diversity of Plasmodium falciparum sporozoite surface antigens derived from analysis of antibodies elicited in humans.

Authors:  B Galey; P Druilhe; I Ploton; C Desgranges; A Asavanich; T Harinasuta; C Marchand; K Brahimi; Y Charoenvit; C Paul
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

2.  A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning.

Authors:  C Guerin-Marchand; P Druilhe; B Galey; A Londono; J Patarapotikul; R L Beaudoin; C Dubeaux; A Tartar; O Mercereau-Puijalon; G Langsley
Journal:  Nature       Date:  1987 Sep 10-16       Impact factor: 49.962

3.  Cultivation of the liver forms of Plasmodium vivax in human hepatocytes.

Authors:  D Mazier; I Landau; P Druilhe; F Miltgen; C Guguen-Guillouzo; D Baccam; J Baxter; J P Chigot; M Gentilini
Journal:  Nature       Date:  1984 Jan 26-Feb 1       Impact factor: 49.962

4.  Species- and stage-specific antigens in exoerythrocytic stages of Plasmodium falciparum.

Authors:  P Druilhe; R M Puebla; F Miltgen; L Perrin; M Gentilini
Journal:  Am J Trop Med Hyg       Date:  1984-05       Impact factor: 2.345

  4 in total
  8 in total

1.  Immunogenicity of four Plasmodium falciparum preerythrocytic antigens in Aotus lemurinus monkeys.

Authors:  B L Perlaza; M Arévalo-Herrera; K Brahimi; G Quintero; J C Palomino; H Gras-Masse; A Tartar; P Druilhe; S Herrera
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

2.  Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3.

Authors:  M Aidoo; A Lalvani; S C Gilbert; J T Hu; P Daubersies; N Hurt; H C Whittle; P Druihle; A V Hill
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

3.  Human antibodies against Plasmodium falciparum liver-stage antigen 3 cross-react with Plasmodium yoelii preerythrocytic-stage epitopes and inhibit sporozoite invasion in vitro and in vivo.

Authors:  K Brahimi; E Badell; J P Sauzet; L BenMohamed; P Daubersies; C Guérin-Marchand; G Snounou; P Druilhe
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

4.  Acquired antibody responses against Plasmodium vivax infection vary with host genotype for duffy antigen receptor for chemokines (DARC).

Authors:  Amanda Maestre; Carlos Muskus; Victoria Duque; Olga Agudelo; Pu Liu; Akihide Takagi; Francis B Ntumngia; John H Adams; Kim Lee Sim; Stephen L Hoffman; Giampietro Corradin; Ivan D Velez; Ruobing Wang
Journal:  PLoS One       Date:  2010-07-15       Impact factor: 3.240

Review 5.  Plasmodium cellular effector mechanisms and the hepatic microenvironment.

Authors:  Ute Frevert; Urszula Krzych
Journal:  Front Microbiol       Date:  2015-05-27       Impact factor: 5.640

Review 6.  Novel approaches to identify protective malaria vaccine candidates.

Authors:  Wan Ni Chia; Yun Shan Goh; Laurent Rénia
Journal:  Front Microbiol       Date:  2014-11-17       Impact factor: 5.640

Review 7.  Vaccine candidate discovery for the next generation of malaria vaccines.

Authors:  James Tuju; Gathoni Kamuyu; Linda M Murungi; Faith H A Osier
Journal:  Immunology       Date:  2017-07-24       Impact factor: 7.397

8.  The malaria candidate vaccine liver stage antigen-3 is highly conserved in Plasmodium falciparum isolates from diverse geographical areas.

Authors:  Eric Prieur; Pierre Druilhe
Journal:  Malar J       Date:  2009-10-29       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.